Parallax Volatility Advisers’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19,300
Closed -$593K 1524
2026
Q1
$593K Sell
19,300
-1,400
-7% -$41K ﹤0.01% 1032
2025
Q4
$600K Buy
+20,700
New +$621K ﹤0.01% 1198
2025
Q1
Sell
-400
Closed -$9.42K 1555
2024
Q4
$9.42K Hold
400
﹤0.01% 1863
2024
Q3
$10.2K Hold
400
﹤0.01% 1926
2024
Q2
$9.39K Buy
+400
New +$10.1K ﹤0.01% 1874
2024
Q1
Sell
-1,700
Closed -$55.8K 1812
2023
Q4
$55.8K Hold
1,700
﹤0.01% 1916
2023
Q3
$47.4K Sell
1,700
-300
-15% -$9.81K ﹤0.01% 2019
2023
Q2
$68.2K Buy
2,000
+1,900
+1,900% +$59.7K ﹤0.01% 2043
2023
Q1
$3.01K Sell
100
-153,200
-100% -$4.75M ﹤0.01% 2531
2022
Q4
$4.33M Buy
153,300
+87,800
+134% +$2.79M 0.01% 1088
2022
Q3
$2.15M Sell
65,500
-54,000
-45% -$1.98M ﹤0.01% 1389
2022
Q2
$3.76M Sell
119,500
-417,500
-78% -$14.6M ﹤0.01% 1079
2022
Q1
$24.7M Buy
537,000
+186,900
+53% +$8.91M 0.01% 435
2021
Q4
$21.4M Buy
350,100
+349,800
+116,600% +$24.2M 0.02% 578
2021
Q3
$22K Sell
300
-86,300
-100% -$7.24M ﹤0.01% 2749
2021
Q2
$8.01M Buy
86,600
+50,000
+137% +$4.25M 0.01% 987
2021
Q1
$3.25M Sell
36,600
-41,800
-53% -$4.15M ﹤0.01% 1491
2020
Q4
$7.31M Buy
+78,400
New +$6.25M 0.01% 1241

Other funds holding ARKG

Parallax Volatility Advisers's ARKG Position: Q2 2026 in Review

Parallax Volatility Advisers reduced its ARK Genomic Revolution ETF (ARKG) stake by 8.3% in Q2 2026, selling an estimated $50.6K and leaving 17,482 shares worth $735K. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

Parallax Volatility Advisers first reported a position in ARKG in Q4 2020 and has held it in 22 quarters since. The position peaked at $11.2M in Q1 2021. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Parallax Volatility Advisers held 17,482 shares of ARK Genomic Revolution ETF worth $735K as of Q2 2026.
  • Parallax Volatility Advisers sold 1,589 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $50.6K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q2 2026, its #1037 holding.
  • Parallax Volatility Advisers first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 22 quarters since.
  • Parallax Volatility Advisers's ARK Genomic Revolution ETF position peaked at $11.2M in Q1 2021.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Parallax Volatility Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.